BioCentury
ARTICLE | Clinical News

External Trigeminal Nerve Stimulation: Phase Ib data

May 21, 2012 7:00 AM UTC

Researchers at the University of California, Los Angeles, reported data from an open-label, U.S. Phase Ib trial in 11 adults with non-psychotic unipolar MDD that lasted >4 months and who have not responded to >=1 antidepressant showing that nightly 8-hour treatment with eTNS significantly reduced HDRS scores by 50% and BDI scores by 58% from baseline. eTNS was well tolerated with no serious adverse events reported during 8-week treatment. Data were presented at the American Psychiatric Association meeting in Philadelphia. ...